AZTR News and Press, Azitra Inc From 05/14/25

2025-05-14 11:35:23 ET More on Azitra Azitra enters share purchase agreement with Alumni Capital for up to $20M Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article ...

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates PR Newswire BRANFORD, Conn. , May 13, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precisio...

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025 PR Newswire Azitra is developing ATR04-484 for the treatment of EGFR inhibitor-associated rash with plans to dose first patient in Phase 1/2 trial in the first half of 2025 BRANFORD, Conn. , Apr...

2025-04-24 16:17:00 ET More on Azitra Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alpha For further details see: Azitra enters share purchase a...

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline PR Newswire BRANFORD, Conn. , April 24, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical co...

Azitra to Present at Microbiome Times Partnering Forum PR Newswire BRANFORD, Conn. , March 12, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermat...

2025-02-25 10:28:15 ET More on Azitra Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alpha For further details see: Azitra reports FY results

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates PR Newswire BRANFORD, Conn. , Feb. 20, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative thera...

2025-02-04 15:25:53 ET More on Azitra Seeking Alpha’s Quant Rating on Azitra Historical earnings data for Azitra Financial information for Azitra Read the full article on Seeking Alpha For further details see: Azitra announces pricing of $9...

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock PR Newswire BRANFORD, Conn. , Feb. 4, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innova...